top of page
  • omkarkadam7989

Transfection Technologies Market Size, Share 2023

The global Transfection Technologies market was valued at US$ 769.1 million in 2022 and is projected to reach US$ 1191.2 million by 2029, at a CAGR of 6.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The USA market for Global Transfection Technologies market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology

The China market for Global Transfection Technologies market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global Transfection Technologies market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

This report aims to provide a comprehensive presentation of the global market for Transfection Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transfection Technologies. This report contains market size and forecasts of Transfection Technologies in global, including the following market information:

  • Global Transfection Technologies Market Revenue, 2018-2023, 2024-2029, ($ millions)

  • Global top five companies in 2022 (%)

Lipofection Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of Transfection Technologies include Bio-Rad, Polyplus Transfection, MaxCyte, Promega Corporation, Thermo Fisher Scientific, Affymetrix, Agilent Technologies, Altogen Biosystems and Boca Scientific, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Transfection Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment:

Global Transfection Technologies Market, by Type, 2018-2023, 2024-2029 ($ millions)

Global Transfection Technologies Market Segment Percentages, by Type, 2022 (%)

  • Lipofection

  • Electroporation

  • Nucleofection

  • Others

Global Transfection Technologies Market, by Application, 2018-2023, 2024-2029 ($ millions)

Global Transfection Technologies Market Segment Percentages, by Application, 2022 (%)

  • Research Centers & Academic/Government Institutes

  • Hospitals & Clinics

  • Pharmaceutical & Biotechnology Companies

  • Others

Global Transfection Technologies Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)

Global Transfection Technologies Market Segment Percentages, By Region and Country, 2022 (%)

  • North America (United States, Canada, Mexico)

  • Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)

  • Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)

  • The Middle East and Africa (Middle East, Africa)

  • South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Transfection Technologies revenues in global market, 2018-2023 (estimated), ($ millions)

  • Key companies Transfection Technologies revenues share in global market, 2022 (%)

key players include:

  • Bio-Rad

  • Polyplus Transfection

  • MaxCyte

  • Promega Corporation

  • Thermo Fisher Scientific

  • Affymetrix

  • Agilent Technologies

  • Altogen Biosystems

  • Boca Scientific

  • Chemicell

  • CytoPulse

  • Clontech

  • Deliverics

  • GE Healthcare Life Sciences

  • IBA GmbH

  • Lonza

  • Inovio Pharmaceuticals

  • Merck KGaA

  • Miltenyi Biotec

  • Oz Biosciences

Outline of Major Chapters:

Chapter 1: Introduces the definition of Transfection Technologies, market overview.

Chapter 2: Global Transfection Technologies market size in revenue.

Chapter 3: Detailed analysis of Transfection Technologies company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Transfection Technologies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.

CONTACT US: 276 5th Avenue, New York , NY 10001,United States International: (+1) 646 781 7170

2 views0 comments

Recent Posts

See All

Comentarios


bottom of page